Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis

Celgene Corporation NASDAQCELG today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration FDA for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis RM...